Flexion Therapeutics to Present at the 42nd Annual Raymond James Virtual Institutional Investors Conference
Get Alerts FLXN Hot Sheet
Join SI Premium – FREE
BURLINGTON, Mass., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led fireside chat at the 42nd Annual Raymond James Institutional Investors Conference. The virtual fireside chat is scheduled to begin at 12:30 p.m. ET on Monday, March 1, 2021.
To access the live webcast of the presentation, please visit the Flexion website at http://ir.flexiontherapeutics.com.
About Flexion TherapeuticsFlexion Therapeutics (Nasdaq: FLXN) is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company's core values are focus, ingenuity, tenacity, transparency and fun. Please visit flexiontherapeutics.com.
Contact:
Scott YoungVice President, Corporate Communications & Investor RelationsFlexion Therapeutics, Inc.T: 781-305-7194[email protected]
Source: Flexion Therapeutics, Inc.Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Partners Value Investments Inc. Announces 2023 Annual Results
- Sachem Capital Sets Dates for 2023 Earnings Release and Conference Call
- Strategic Storytelling for Internal Communications Online Seminar: April 30, 2024 May 1-2, 2024 - Using Storytelling to Engage Employees, Manage Organizational Change, and Shape Workplace Cultures
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Raymond JamesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!